HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%

Reuters

07/25

HCA Healthcare <a href="https://laohu8.com/S/QTWO">Q2</a> Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%

HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2554957764"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2554957764\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2554957764?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-25 19:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2554957764","market":"nz","top_or_hot":-1,"title":"HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HCA Healthcare <a href=\"https://laohu8.com/S/QTWO\">Q2</a> Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-25 19:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      HCA Healthcare <a href=\"https://laohu8.com/S/QTWO\">Q2</a> Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCA","symbol_name":"HCA控股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250725:nNDL9VMrKB:1","article_id":"2554957764","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2554957764","pubTimestamp":1753443032,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"HCA":"HCA控股"},"translate_title":"HCA Healthcare第二季度业绩：收入增长6.4%至$18.605 B，净利润增长13.1%，每股收益增长23.5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCA":0.9},"content_text":"HCA Healthcare Q2 Results: Revenues Rise 6.4% to $18.605B, Net Income Up 13.1%, EPS Climbs 23.5%\n    \n\n        HCA Healthcare Inc. has announced its financial results for the second quarter of 2025, reporting a revenue increase of 6.4% to $18.605 billion compared to the same period in 2024. The company also saw a 13.1% rise in net income attributable to HCA Healthcare, Inc., totaling $1.653 billion. Diluted earnings per share grew significantly by 23.5% to $6.83 per share. Adjusted EBITDA experienced an 8.4% increase, reaching $3.849 billion. Additionally, cash flows from operating activities more than doubled, amounting to $4.210 billion compared to $1.971 billion in the second quarter of the previous year. HCA Healthcare has raised its guidance for 2025, with capital expenditures, excluding acquisitions, anticipated to be around $5.0 billion. The company's outlook is based on current expectations regarding volume growth and a mostly stable operating environment. Same facility admissions saw a rise of 1.8%, with equivalent admissions increasing by 1.7%.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HCA Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250725759537) on July 25, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}